Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LXRX · against 480 other Healthcare companies of similar size
Ranked #410 of 481 · scores higher than 14% of peers
Bars: peers in each 10-point band of the profitability score46 peers with a profitability score of 10–19, including LXRX · Click a bar to see the companies
Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | LXRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 455 reported | -23.3% | 2.7% | 18% | 33% | |
| Operating marginHigher is better · 451 reported | -131.4% | 4.8% | 11% | 33% | |
| Return on assetsHigher is better · 476 reported | -24.4% | 1.0% | 16% | 33% | |
| Return on equityHigher is better · 456 reported | -40.2% | 1.6% | 16% | Context only | |
| Gross marginHigher is better · 497 reported | 86.0% | 42.8% | 92% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 404 | 519M USD | 17 | 22 | |
| 410 | 3.5B HKD (≈$451M) | 16 | 51 | |
| 410 | 1.1B USD | 16 | 50 | |
| 410 | 1.3B USD | 16 | 30 | |
| 410 | 650M USD | 16 | 48 | |
| 410 | 643M USD | 16 | 31 | |
| 415 | 642M USD | 15 | 46 | |
| 415 | 424M USD | 15 | 45 | |
| 417 | 11.6B TWD (≈$360M) | 14 | 45 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score